These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2083 related articles for article (PubMed ID: 22607822)
1. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. ; Mihaylova B; Emberson J; Blackwell L; Keech A; Simes J; Barnes EH; Voysey M; Gray A; Collins R; Baigent C Lancet; 2012 Aug; 380(9841):581-90. PubMed ID: 22607822 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. ; Baigent C; Blackwell L; Emberson J; Holland LE; Reith C; Bhala N; Peto R; Barnes EH; Keech A; Simes J; Collins R Lancet; 2010 Nov; 376(9753):1670-81. PubMed ID: 21067804 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Cholesterol Treatment Trialists' Collaboration Lancet; 2019 Feb; 393(10170):407-415. PubMed ID: 30712900 [TBL] [Abstract][Full Text] [Related]
4. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. ; Herrington WG; Emberson J; Mihaylova B; Blackwell L; Reith C; Solbu MD; Mark PB; Fellström B; Jardine AG; Wanner C; Holdaas H; Fulcher J; Haynes R; Landray MJ; Keech A; Simes J; Collins R; Baigent C Lancet Diabetes Endocrinol; 2016 Oct; 4(10):829-39. PubMed ID: 27477773 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Baigent C; Keech A; Kearney PM; Blackwell L; Buck G; Pollicino C; Kirby A; Sourjina T; Peto R; Collins R; Simes R; Lancet; 2005 Oct; 366(9493):1267-78. PubMed ID: 16214597 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. ; Fulcher J; O'Connell R; Voysey M; Emberson J; Blackwell L; Mihaylova B; Simes J; Collins R; Kirby A; Colhoun H; Braunwald E; La Rosa J; Pedersen TR; Tonkin A; Davis B; Sleight P; Franzosi MG; Baigent C; Keech A Lancet; 2015 Apr; 385(9976):1397-405. PubMed ID: 25579834 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis. Sabatine MS; Wiviott SD; Im K; Murphy SA; Giugliano RP JAMA Cardiol; 2018 Sep; 3(9):823-828. PubMed ID: 30073316 [TBL] [Abstract][Full Text] [Related]
8. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. Silverman MG; Ference BA; Im K; Wiviott SD; Giugliano RP; Grundy SM; Braunwald E; Sabatine MS JAMA; 2016 Sep; 316(12):1289-97. PubMed ID: 27673306 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. ; Kearney PM; Blackwell L; Collins R; Keech A; Simes J; Peto R; Armitage J; Baigent C Lancet; 2008 Jan; 371(9607):117-25. PubMed ID: 18191683 [TBL] [Abstract][Full Text] [Related]
10. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials. Marston NA; Giugliano RP; Im K; Silverman MG; O'Donoghue ML; Wiviott SD; Ference BA; Sabatine MS Circulation; 2019 Oct; 140(16):1308-1317. PubMed ID: 31530008 [TBL] [Abstract][Full Text] [Related]
11. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Heart Protection Study Collaborative Group Lancet; 2011 Dec; 378(9808):2013-2020. PubMed ID: 22115874 [TBL] [Abstract][Full Text] [Related]
12. Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants. Wang N; Fulcher J; Abeysuriya N; Park L; Kumar S; Di Tanna GL; Wilcox I; Keech A; Rodgers A; Lal S Lancet Diabetes Endocrinol; 2020 Jan; 8(1):36-49. PubMed ID: 31862150 [TBL] [Abstract][Full Text] [Related]
13. Interpretation of the evidence for the efficacy and safety of statin therapy. Collins R; Reith C; Emberson J; Armitage J; Baigent C; Blackwell L; Blumenthal R; Danesh J; Smith GD; DeMets D; Evans S; Law M; MacMahon S; Martin S; Neal B; Poulter N; Preiss D; Ridker P; Roberts I; Rodgers A; Sandercock P; Schulz K; Sever P; Simes J; Smeeth L; Wald N; Yusuf S; Peto R Lancet; 2016 Nov; 388(10059):2532-2561. PubMed ID: 27616593 [TBL] [Abstract][Full Text] [Related]
14. Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials. Burger PM; Dorresteijn JAN; Koudstaal S; Holtrop J; Kastelein JJP; Jukema JW; Ridker PM; Mosterd A; Visseren FLJ Atherosclerosis; 2024 Sep; 396():118540. PubMed ID: 39126771 [TBL] [Abstract][Full Text] [Related]
15. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis. ; Lancet Diabetes Endocrinol; 2024 May; 12(5):306-319. PubMed ID: 38554713 [TBL] [Abstract][Full Text] [Related]
16. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. ; Emberson JR; Kearney PM; Blackwell L; Newman C; Reith C; Bhala N; Holland L; Peto R; Keech A; Collins R; Simes J; Baigent C PLoS One; 2012; 7(1):e29849. PubMed ID: 22276132 [TBL] [Abstract][Full Text] [Related]
17. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Baigent C; Landray MJ; Reith C; Emberson J; Wheeler DC; Tomson C; Wanner C; Krane V; Cass A; Craig J; Neal B; Jiang L; Hooi LS; Levin A; Agodoa L; Gaziano M; Kasiske B; Walker R; Massy ZA; Feldt-Rasmussen B; Krairittichai U; Ophascharoensuk V; Fellström B; Holdaas H; Tesar V; Wiecek A; Grobbee D; de Zeeuw D; Grönhagen-Riska C; Dasgupta T; Lewis D; Herrington W; Mafham M; Majoni W; Wallendszus K; Grimm R; Pedersen T; Tobert J; Armitage J; Baxter A; Bray C; Chen Y; Chen Z; Hill M; Knott C; Parish S; Simpson D; Sleight P; Young A; Collins R; Lancet; 2011 Jun; 377(9784):2181-92. PubMed ID: 21663949 [TBL] [Abstract][Full Text] [Related]
18. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Heart Protection Study Collaborative Group Lancet; 2002 Jul; 360(9326):7-22. PubMed ID: 12114036 [TBL] [Abstract][Full Text] [Related]
19. Statins for the primary prevention of cardiovascular disease. Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795 [TBL] [Abstract][Full Text] [Related]
20. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Law MR; Wald NJ; Rudnicka AR BMJ; 2003 Jun; 326(7404):1423. PubMed ID: 12829554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]